Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2020

Details for Mechanism ID: 18504
Country/Region: Kenya
Year: 2017
Main Partner: University of Maryland
Main Partner Program: University of Maryland Baltimore
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $11,467,637 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $628,264
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $1,054,087
Testing: HIV Testing and Counseling (HVCT) $1,352,838
Sexual Prevention: Other Sexual Prevention (HVOP) $40,926
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $849,142
Treatment: Adult Treatment (HTXS) $6,763,080
Treatment: Pediatric Treatment (PDTX) $779,300
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2018 362
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 2,990
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 19,899
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 7,472
GEND_GBV Number of people receiving post-GBV care 2018 27,371
HTS_TST By Key Population: FSW, Negative 2018 4
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 537,956
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 2
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 2
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 1
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 1
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 3
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 641
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 5,866
HTS_TST Service Delivery Point (Facility) VMMC: <15, Negative 2018 8,397
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 1,063
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 644
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 2,383
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 1,343
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: <15, Negative 2018 400
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 49,572
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 940
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 906
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 5,012
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 2,816
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 34,906
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 32,947
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 218,449
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 144,190
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Female, Negative 2018 272
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Male, Negative 2018 252
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 1,131
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 763
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative 2018 80
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative 2018 75
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 254
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 154
HTS_TST Service Delivery Point by Agg Age (Facility) VMMC: 15+, Negative 2018 11,044
HTS_TST Sum of Test Result disaggregates 2018 10,266
HTS_TST_POS By Test Result: Positive 2018 10,266
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 18
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 35
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 137
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: <15, Positive 2018 5
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 1,448
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 29
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 43
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 188
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 173
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 5,575
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 2,263
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: Unknown Age, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 86
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 54
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VMMC: <15, Positive 2018 11
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VMMC: 15+, Positive 2018 271
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 710
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 100
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 8
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 818
PMTCT_ART Already on ART at beginning of current pregnancy 2018 2,946
PMTCT_ART New on ART 2018 1,154
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 4,100
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 51,562
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 4,101
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 1,312
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 2,666
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 79
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 44
PMTCT_STAT By Age (Numerator): 10-14 2018 405
PMTCT_STAT By Age (Numerator): 15-19 2018 11,848
PMTCT_STAT By Age (Numerator): 20-24 2018 27,889
PMTCT_STAT By Age (Numerator): 25-49 2018 11,379
PMTCT_STAT By Age (Numerator): 50+ 2018 41
PMTCT_STAT By Number of known positives: 15-19 2018 125
PMTCT_STAT By Number of known positives: 20-24 2018 1,210
PMTCT_STAT By Number of known positives: 25-49 2018 1,427
PMTCT_STAT By Number of new negative: 10-14 2018 400
PMTCT_STAT By Number of new negative: 15-19 2018 11,570
PMTCT_STAT By Number of new negative: 20-24 2018 25,804
PMTCT_STAT By Number of new negative: 25-49 2018 9,521
PMTCT_STAT By Number of new negative: 50+ 2018 41
PMTCT_STAT By Number of new positives: 10-14 2018 5
PMTCT_STAT By Number of new positives: 15-19 2018 85
PMTCT_STAT By Number of new positives: 20-24 2018 838
PMTCT_STAT By Number of new positives: 25-49 2018 536
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 51,562
PMTCT_STAT_den By Age (Denominator): <15-19 2018 13,154
PMTCT_STAT_den By Age (Denominator): 10-14 2018 460
PMTCT_STAT_den By Age (Denominator): 20-24 2018 31,028
PMTCT_STAT_den By Age (Denominator): 25-49 2018 12,650
PMTCT_STAT_den By Age (Denominator): 50+ 2018 47
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 12
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 569
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 18
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 347
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 955
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 946
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 13
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 567
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 18
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 357
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 64
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,004
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 50
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,258
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 2,379
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 2,396
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 64
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,000
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 51
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,277
TX_CURR Aggregated Age/Sex: <15 Female 2018 2,693
TX_CURR Aggregated Age/Sex: <15 Male 2018 2,447
TX_CURR Aggregated Age/Sex: 15+ Female 2018 49,342
TX_CURR Aggregated Age/Sex: 15+ Male 2018 20,939
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 75,421
TX_CURR Sum of Aggregated Age/Sex <15 2018 5,140
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 70,281
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 75,421
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 368
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 215
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 5,889
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 3,787
TX_NEW Breastfeeding status 2018 162
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 10,259
TX_NEW Pregnancy status 2018 1,191
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 10,259
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 74,676
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 66,880
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 2,081
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 186
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,670
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 61
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 42,016
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 3,259
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 16,238
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,005
TX_PVLS Numerator: Indication: Routine 2018 62,369
TX_PVLS Numerator: Indication: Targeted 2018 4,504
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 636
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 424
TX_PVLS Undocumented Test Indication 2018 7
TX_PVLS Unknown Age, Targeted, Female 2018 4
TX_PVLS Unknown Age, Targeted, Male 2018 5
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 2,561
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 396
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 2,263
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 184
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 46,187
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 3,554
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 18,033
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,349
TX_PVLS_den Denominator: Indication: Routine 2018 69,023
TX_PVLS_den Denominator: Indication: Targeted 2018 5,493
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 511
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 549
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 346
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 284
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 6,562
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2,554
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 9,746
TX_RET Numerator by Status: Breastfeeding 2018 261
TX_RET Numerator by Status: Pregnant 2018 979
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 11,289
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 371
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 287
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 6,883
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,573
TX_RET_den Denominator by Status: Breastfeeding 2018 196
TX_RET_den Denominator by Status: Pregnant 2018 763
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 379
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 379
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 16
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 7
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 213
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 143
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 112
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 11
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 117
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 131
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 95
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 5
TX_TB_den Denominator: By Screen Result: Negative 2018 271
TX_TB_den Denominator: By Screen Result: Positive 2018 100
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 100
VMMC_CIRC By Age: 0-60 days 2018 1,000
VMMC_CIRC By Age: 10-14 2018 7,808
VMMC_CIRC By Age: 15-19 2018 1,952
VMMC_CIRC By Age: 20-24 2018 1,952
VMMC_CIRC By Age: 25-29 2018 3,904
VMMC_CIRC By Age: 30-49 2018 2,709
VMMC_CIRC By Age: 50+ 2018 195
VMMC_CIRC By circumcision technique: Device-based VMMC 2018 450
VMMC_CIRC By circumcision technique: Surgical VMMC 2018 19,070
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2018 19,520
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2018 18,520
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2018 11,907
Cross Cutting Budget Categories and Known Amounts Total: $2,521,984
Key Populations: Sex Workers $1,539,567
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Key Populations: MSM and TG $81,030
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Gender: Gender Based Violence (GBV) $10,000
GBV Prevention
Implementation
Capacity building
Post GBV Care
Implementation
Capacity building
Human Resources for Health $891,387